Skip to main content

Table 2 Basic information of patients

From: Prognostic analysis of patients with stage IIIC1p cervical cancer treated by surgery

Variables

Cases, n (%)

Age(years)

 ≤ 54

73 (71.6)

  > 54

29 (28.4)

Surgical method

 Laparoscope

82 (80.4)

 Laparotomy

20 (19.6)

Postoperative treatment

 None

10 (9.8)

 Chemotherapy

40 (39.2)

 Chemo plus radiotherapy

52 (51.0)

Ovarian status

 Ovarian transposition

23 (22.5)

 Ovariectomy

79 (77.5)

Intraoperative blood loss(ml)

  ≤ 250

76 (74.5)

  > 250

26 (25.5)

Perioperative complications

 Negative

76 (74.5)

 Positive

26 (25.5)

Pathological type

 Squamous cell carcinoma

80 (78.4)

 Adenocarcinoma

16 (15.7)

 Adeno-squamous carcinoma

6 (5.9)

Tumor size (cm)

  ≤ 4

61 (59.8)

  > 4

41 (40.2)

LNR

  ≤ 0.3

79 (77.5)

  > 0.3

23 (22.5)

DSI

  ≤ 1/2

10 (9.8)

  > 1/2

92 (90.2)

LVSI

 Positive

59 (57.8)

 Negative

43 (42.3)

Vagina margin

 Positive

43 (42.3)

 Negative

59 (57.8)

Parametrium

 Positive

12 (11.8)

 Negative

90(88.2)

NLR

  ≤ 3.8

88(86.3)

  > 3.8

14 (13.7)

  1. LNR Lymph node ratio, DSI Deep stromal infiltration, LVSI Lymph vascular space invasion, NLR Neutrophil lymphocyte ratio